Morgan Stanley Maintains Rating on Oracle (ORCL)

Morgan Stanley Maintains Rating on Oracle (ORCL)


Morgan Stanley reported on Thursday that they have reaffirmed their rating on computer technology company, Oracle Corporation(ORCL).

The firm reported that they have maintained their “Overweight” rating for ORCL as underlying fundamentals have improved.

A Morgan Stanley analyst commented, “ORCL’s 10-Q showed: 1) organic cc license growth better than we first modeled, 2) a much better large deal environment, 3) good deferred license coverage and 4) margin improvements coming from both efficiency gains and mix shift. Additionally, SW maint. margins continued at all-time highs, giving us confidence that ORCL can continue to protect and grow EPS – which should be aided by continued repurchases given a strong QoQ increase in onshore cash (despite another large buyback). With sales capacity ramping well, Fusion Apps accelerating, Exa-series sustaining strong growth and mild comps continuing ahead, the stock is easier to own than most headed into CY13.”

Oracle shares were down 53 cents, or -1.58% during Thursday afternoon trading. The stock is up 28.8% YTD.

The Bottom Line
Shares of Oracle Corporation (ORCL) have a .71% dividend yield, based on last night’s closing stock price of $33.61. The stock has technical support in the $30 price area. If the shares can firm up, we see overhead resistance around the $35-$36 price levels.

Oracle Corporation(ORCL) is not recommended at this time, holding a DARS™ Rating of 3.2 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today